MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$144.25
−0.32%Price chart
Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8Sep 11
ValuationView details →
P/E (Fwd)
16.7x
EV/EBITDA
29.1x
Market Cap
$355.89B
MomentumView details →
1D Return
−0.32%
YTD Return
+37.42%
RSI (14)
51.6
ValuationView details →
P/E (Fwd)
16.7x
EV/EBITDA
29.1x
Market Cap
$355.89B
RSI (14)
51.6
MomentumView details →
1D Return
−0.32%
YTD Return
+37.42%
SummaryUpdated Jun 1, 2026
Merck & Co., Inc. (NYSE:MRK) is one of the world's largest pharmaceutical companies, founded in 1891 and headquartered in Kenilworth, New Jersey. Originally established as the American subsidiary of the German chemical company E. Merck, the company became independent during World War I and has since evolved into a global healthcare leader. Today, Merck operates as a diversified healthcare company serving patients worldwide through two primary business segments: pharmaceuticals for human health and animal health products. The company has built its reputation on developing breakthrough medicines and vaccines that address some of the most challenging diseases facing humanity.
Similar companies
Latest newsMore news →
In US after-hours trading on September 11, 2026, most pharmaceutical and biotech stocks rose, with Eli Lilly up 0.03%, Johnson & Johnson up 0.32%, Merck up 0.09%, Novartis up 0.14%, AstraZeneca up 0.38% and Novo Nordisk up 0.11%.11h agoMerck shares closed at $144.71 on the most recent trading day, falling 1.91% and underperforming the S&P 500's 0.59% decline.18h agoBiopharma stocks including AbbVie, Amgen, Eli Lilly, Johnson & Johnson, and Merck rallied on Wednesday, with Merck jumping 12.4%.23d ago